États-Unis · Actualité générale · Time

A Personalized Cancer Vaccine Lowers Melanoma Recurrence by 42%

Publié par Time · États-Unis il y a 9 h

The treatment is still experimental, but results from Moderna and Merck add scientific support for a vaccine-based approach to treating the cancer.

Lire l'article complet sur Time Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (time.com)

À lire aussi

Chris LaCivita and James Blair donate full Bosnian consulting fee to Trump presidential library

Hegseth staff damaged WWII-era Eisenhower globe trying to move it to his office

At least 16 dead when powerful 7.0 magnitude earthquake strikes Tibet

RFK Jr. adviser Calley Means resigns amid growing MAHA discontent over lack of progress

Rollins: Trump administration going ‘full-bore ahead’ on Forest Service reorganization

‘If Anything Happens to This Guy … Everyone Is Screwed’